Eric Raymond - Service interhospitalier de cancérologie Bichat-Beaujon, hôpital Beaujon

基本信息

浏览量：17

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 484 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

395MO Tislelizumab (TIS) + Chemotherapy (CT) Vs Placebo (PBO) + CT in Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): PD-L1 Biomarker Analysis from RATIONALE-306

E. Raymond, J. Xu, K. Kato,R. Hubner,Y. Shu,S.R. Park,T. Kojima,L.S. Wyrwicz,D. Tougeron,K. Geboes,E. Van Cutsem,R.A. Pazo Cid,A. Zaanan,S-A. McLachlan, H. Wu,J. Shi, L. Li, S. Yan,H. Yoon

Annals of Oncology (2024): S159

引用0浏览0引用

Tislelizumab (TIS) Plus Chemotherapy (CT) Vs Placebo (PBO) Plus CT in Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): PD-L1 Biomarker Analysis from RATIONALE-306

E. Raymond,J. Xu,K. Kato,R. Hubner,Y. Shu,S. R. Park, T. Kojima,L. S. Wyrwicz,D. Tougeron,K. Geboes,E. Van Cutsem,R. A. Pazo Cid,A. Zaanan,S-A. McLachlan, H. Wu,J. Shi, L. Li, S. Yan,H. Yoon

ANNALS OF ONCOLOGY (2024): S159-S159

引用0浏览0引用

Identification of a Central Network Hub of Key Prognostic Genes Based on Correlation Between Transcriptomics and Survival in Patients with Metastatic Solid Tumors

Vladimir Lazar,Eric Raymond,Shai Magidi,Catherine Bresson,Fanny Wunder,Ioana Berindan-Neagoe, Annemilai Tijeras-Rabaland,Jacques Raynaud,Amir Onn,Michel Ducreux,Gerald Batist,Ulrik Lassen, Fin Cilius Nielsen,Richard L. Schilsky,Eitan Rubin,Razelle Kurzrock

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024)

引用0浏览0WOS引用

PCR65 Examining the Impact of Tislelizumab Added to Chemotherapy on Health-Related Quality of Life (hrqol) Outcomes in Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC): the Rationale-306 Study

J. Xu,P. Jiménez-Fonseca, K. Kato,Y. Shu,S.R. Park,R. Hubner,E. Raymond,H.H. Yoon, S. Yan, B. Barnes, S. Mardiguian,G. Barnes

Value in Healthno. 12 (2024): S517

引用0浏览0引用

Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances

Soledad Iseas,Golubicki Mariano, Louis Gros,Nabil Baba-Hamed,Vincent De Parades,Julien Adam,Eric Raymond,Martin Carlos Abba

Molecular Diagnosis & Therapyno. 2 (2024): 201-214

引用2浏览0WOS引用

Real-life Clinical and Organizational Evaluation of Telemonitoring and Assisted Telemonitoring in More Than 1500 Cancer Patients

S. Martin, A. Fritsch,C. Jouannaud,J. Martin-Babau,B. Mennecier,F. Slimano, A. Bordeau, L. Gueroult-Accolas, B. Delcour,E. Raymond, S. Renet, C. Sonntag,A. Morel,P. Barthelemy

ANNALS OF ONCOLOGY (2023): S1230-S1230

引用0浏览0引用

Targeting PPT1 with Ezurpimtrostat Sensitives Liver Tumor to Immunotherapy by Switching Cold into Hot Microenvironments

Eloïne Bestion,Madani Rachid,Annemilaï Tijeras-Raballand,Gael Roth,Thomas Decaens,Christelle Ansaldi,Soraya Mezouar,Eric Raymond,Philippe Halfon

biorxiv（2023）

引用1浏览0引用

Randomized, Global, Phase III Study of Tislelizumab (TIS) Plus Chemotherapy (chemo) Vs Placebo (PBO) Plus Chemo As First-Line (1L) Treatment for Advanced/metastatic Esophageal Squamous Cell Carcinoma (ESCC): RATIONALE-306 Update

R. Hubner, J. Xu, K. Kato,E. Raymond,Y. Shu,Y. Pan, Y. Jiang, J. Zhang,S. R. Park,T. Kojima,C-Y. Lin,E. Gotovkin,L. S. Wyrwicz,R. Ishihara, H. Wu,Y. Peng, L. Wang, L. Li,H. Yoon

ANNALS OF ONCOLOGY（2023）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn